[1] L. Zhu, H. Zhao, Z. Zhou, Y. Xia, Z. Wang, H. Ran, P. Li, J. Ren, Peptide-Functionalized Phase-Transformation Nanoparticles for Low Intensity Focused Ultrasound-Assisted Tumor Imaging and Therapy, Nano Letters. 18 (2018) 1831–1841. doi:10.1021/acs.nanolett.7b05087.
[2] Q. Zhou, Y. Zeng, Q. Xiong, S. Zhong, P. Li, H. Ran, Y. Yin, C. Reutelingsperger, F.W. Prinze, Z. Ling, Construction of CNA35 Collagen-Targeted Phase-Changeable Nanoagents for Low-Intensity Focused Ultrasound-Triggered Ultrasound Molecular Imaging of Myocardial Fibrosis in Rabbits, ACS Applied Materials & Interfaces. 11 (2019) 23006–23017. doi:10.1021/acsami.9b05999.
[3] M. Wang, Q. Yang, M. Li, H. Zou, Z. Wang, H. Ran, Y. Zheng, J. Jian, Y. Zhou, Y. Luo, Y. Ran, S. Jiang, X. Zhou, Multifunctional Nanoparticles for Multimodal Imaging-Guided Low-Intensity Focused Ultrasound/Immunosynergistic Retinoblastoma Therapy, ACS Applied Materials & Interfaces. 12 (2020) 5642–5657. doi:10.1021/acsami.9b22072.
[4] Y. Zhong, Y. Zhang, J. Xu, J. Zhou, J. Liu, M. Ye, L. Zhang, B. Qiao, Z. Wang, H. Ran, D. Guo, Low-Intensity Focused Ultrasound-Responsive Phase-Transitional Nanoparticles for Thrombolysis without Vascular Damage: A Synergistic Nonpharmaceutical Strategy, ACS Nano. 13 (2019) 3387–3403. doi:10.1021/acsnano.8b09277.
[5] N.A. Tokranova, S.W. Novak, J. Castracane, I.A. Levitsky, Deep Infiltration of Emissive Polymers into Mesoporous Silicon Microcavities: Nanoscale Confinement and Advanced Vapor Sensing, The Journal of Physical Chemistry C. 117 (2013) 22667–22676. doi:10.1021/jp405071n.
[6] J. Liu, F. Xu, J. Huang, J. Xu, Y. Liu, Y. Yao, M. Ao, A. Li, L. Hao, Y. Cao, Z. Hu, H. Ran, Z. Wang, P. Li, Low-intensity focused ultrasound (LIFU)-activated nanodroplets as a theranostic agent for noninvasive cancer molecular imaging and drug delivery, Biomaterials Science. 6 (2018) 2838–2849. doi:10.1039/C8BM00726H.
[7] A. Yang, B. Qiao, E.M. Strohm, J. Cao, Z. Wang, X. Yuan, Y. Luo, Y. Sun, Thrombin-responsive engineered nanoexcavator with full-thickness infiltration capability for pharmaceutical-free deep venous thrombosis theranostics, Biomaterials Science. 8 (2020) 4545–4558. doi:10.1039/D0BM00917B.
[8] Y. Wang, G. Sui, D. Teng, Q. Wang, J. Qu, L. Zhu, H. Ran, Z. Wang, C. Jin, H. Wang, Low intensity focused ultrasound (LIFU) triggered drug release from cetuximab-conjugated phase-changeable nanoparticles for precision theranostics against anaplastic thyroid carcinoma, Biomaterials Science. 7 (2019) 196–210. doi:10.1039/C8BM00970H.
[9] T. Iwashina, J. Mochida, T. Miyazaki, T. Watanabe, S. Iwabuchi, K. Ando, T. Hotta, D. Sakai, Low-intensity pulsed ultrasound stimulates cell proliferation and proteoglycan production in rabbit intervertebral disc cells cultured in alginate, Biomaterials. 27 (2006) 354–361. doi:https://doi.org/10.1016/j.biomaterials.2005.06.031.
[10] Y. Kang, J. Kim, J. Park, Y.M. Lee, G. Saravanakumar, K.M. Park, W. Choi, K. Kim, E. Lee, C. Kim, W.J. Kim, Tumor vasodilation by N-Heterocyclic carbene-based nitric oxide delivery triggered by high-intensity focused ultrasound and enhanced drug homing to tumor sites for anti-cancer therapy, Biomaterials. 217 (2019) 119297. doi:https://doi.org/10.1016/j.biomaterials.2019.119297.
[11] Y.-J. Ho, C.-H. Wu, Q. Jin, C.-Y. Lin, P.-H. Chiang, N. Wu, C.-H. Fan, C.-M. Yang, C.-K. Yeh, Superhydrophobic drug-loaded mesoporous silica nanoparticles capped with β-cyclodextrin for ultrasound image-guided combined antivascular and chemo-sonodynamic therapy, Biomaterials. 232 (2020) 119723. doi:https://doi.org/10.1016/j.biomaterials.2019.119723.
[12] Y. Wang, J. Zhang, X. Lv, L. Wang, Z. Zhong, D.-P. Yang, W. Si, T. Zhang, X. Dong, Mitoxantrone as photothermal agents for ultrasound/fluorescence imaging-guided chemo-phototherapy enhanced by intratumoral H2O2-Induced CO, Biomaterials. 252 (2020) 120111. doi:https://doi.org/10.1016/j.biomaterials.2020.120111.
[13] J. Pan, L. Zhang, S. Xu, X. Cheng, H. Yu, J. Bao, R. Lu, Induction of Apoptosis in Human Papillary-Thyroid-Carcinoma BCPAP Cells by Diallyl Trisulfide through Activation of the MAPK Signaling Pathway, Journal of Agricultural and Food Chemistry. 66 (2018) 5871–5878. doi:10.1021/acs.jafc.8b02243.
[14] A. Cutignano, B. Seetharamsingh, D. D’Angelo, G. Nuzzo, P. V Khairnar, A. Fusco, D.S. Reddy, A. Fontana, Identification and Synthesis of Mycalol Analogues with Improved Potency against Anaplastic Thyroid Carcinoma Cell Lines, Journal of Natural Products. 80 (2017) 1125–1133. doi:10.1021/acs.jnatprod.7b00043.
[15] D. Paolino, D. Cosco, M. Licciardi, G. Giammona, M. Fresta, G. Cavallaro, Polyaspartylhydrazide Copolymer-Based Supramolecular Vesicular Aggregates as Delivery Devices for Anticancer Drugs, Biomacromolecules. 9 (2008) 1117–1130. doi:10.1021/bm700964a.
[16] J. Zheng, X. Cheng, S. Xu, L. Zhang, J. Pan, H. Yu, J. Bao, R. Lu, Diallyl trisulfide induces G2/M cell-cycle arrest and apoptosis in anaplastic thyroid carcinoma 8505C cells, Food & Function. 10 (2019) 7253–7261. doi:10.1039/C9FO00646J.
[17] A. Balbín, F. Gaballo, J. Ceballos-Torres, S. Prashar, M. Fajardo, G.N. Kaluđerović, S. Gómez-Ruiz, Dual application of Pd nanoparticles supported on mesoporous silica SBA-15 and MSU-2: supported catalysts for C–C coupling reactions and cytotoxic agents against human cancer cell lines, RSC Advances. 4 (2014) 54775–54787. doi:10.1039/C4RA11759J.
[18] J.P. Parker, Z. Ude, C.J. Marmion, Exploiting developments in nanotechnology for the preferential delivery of platinum-based anti-cancer agents to tumours: targeting some of the hallmarks of cancer, Metallomics. 8 (2016) 43–60. doi:10.1039/C5MT00181A.
[19] M. Zhou, Y. Chen, M. Adachi, X. Wen, B. Erwin, O. Mawlawi, S.Y. Lai, C. Li, Single agent nanoparticle for radiotherapy and radio-photothermal therapy in anaplastic thyroid cancer, Biomaterials. 57 (2015) 41–49. doi:https://doi.org/10.1016/j.biomaterials.2015.04.013.
[20] X. Kong, P. Pan, H. Sun, H. Xia, X. Wang, Y. Li, T. Hou, Drug Discovery Targeting Anaplastic Lymphoma Kinase (ALK), Journal of Medicinal Chemistry. 62 (2019) 10927–10954. doi:10.1021/acs.jmedchem.9b00446.
[21] L. Lee, L.M. Robb, M. Lee, R. Davis, H. Mackay, S. Chavda, B. Babu, E.L. O’Brien, A.L. Risinger, S.L. Mooberry, M. Lee, Design, Synthesis, and Biological Evaluations of 2,5-Diaryl-2,3-dihydro-1,3,4-oxadiazoline Analogs of Combretastatin-A4, Journal of Medicinal Chemistry. 53 (2010) 325–334. doi:10.1021/jm901268n.
[22] A. Arcinas, T.-Y. Yen, E. Kebebew, B.A. Macher, Cell Surface and Secreted Protein Profiles of Human Thyroid Cancer Cell Lines Reveal Distinct Glycoprotein Patterns, Journal of Proteome Research. 8 (2009) 3958–3968. doi:10.1021/pr900278c.
[23] Y. Hu, X.-Z. Dong, X. Liu, P. Liu, Y.-B. Chen, Enhanced Antitumor Activity of Cetuximab in Combination with the Jak Inhibitor CYT387 against Non-Small-Cell Lung Cancer with Various Genotypes, Molecular Pharmaceutics. 13 (2016) 689–697. doi:10.1021/acs.molpharmaceut.5b00927.
[24] D. Zeng, Y. Guo, A.G. White, Z. Cai, J. Modi, R. Ferdani, C.J. Anderson, Comparison of Conjugation Strategies of Cross-Bridged Macrocyclic Chelators with Cetuximab for Copper-64 Radiolabeling and PET Imaging of EGFR in Colorectal Tumor-Bearing Mice, Molecular Pharmaceutics. 11 (2014) 3980–3987. doi:10.1021/mp500004m.
[25] S. Heskamp, O.C. Boerman, J.D.M. Molkenboer-Kuenen, F.C.G.J. Sweep, A. Geurts-Moespot, M.S. Engelhardt, W.T.A. van der Graaf, W.J.G. Oyen, H.W.M. van Laarhoven, Cetuximab Reduces the Accumulation of Radiolabeled Bevacizumab in Cancer Xenografts without Decreasing VEGF Expression, Molecular Pharmaceutics. 11 (2014) 4249–4257. doi:10.1021/mp500460g.
[26] F.L. Sung, R.T.K. Pang, B.B.Y. Ma, M.M.L. Lee, S.M. Chow, T.C.W. Poon, A.T.C. Chan, Pharmacoproteomics Study of Cetuximab in Nasopharyngeal Carcinoma, Journal of Proteome Research. 5 (2006) 3260–3267. doi:10.1021/pr050452g.
[27] H. Kim, S.-H. Goh, Y. Choi, Quenched cetuximab conjugate for fast fluorescence imaging of EGFR-positive lung cancers, Biomaterials Science. (2020). doi:10.1039/D0BM01148G.
[28] D.-H. Kim, D.-K. Kim, K. Zhou, S. Park, Y. Kwon, M.G. Jeong, N.K. Lee, S.H. Ryu, Single particle tracking-based reaction progress kinetic analysis reveals a series of molecular mechanisms of cetuximab-induced EGFR processes in a single living cell, Chemical Science. 8 (2017) 4823–4832. doi:10.1039/C7SC01159H.
[29] L. García-Fernández, J. Garcia-Pardo, O. Tort, I. Prior, M. Brust, E. Casals, J. Lorenzo, V.F. Puntes, Conserved effects and altered trafficking of Cetuximab antibodies conjugated to gold nanoparticles with precise control of their number and orientation, Nanoscale. 9 (2017) 6111–6121. doi:10.1039/C7NR00947J.
[30] J. Kim, S.Y. Woo, C.Y. Im, E.K. Yoo, S. Lee, H.-J. Kim, H.-J. Hwang, J. Cho, W.S. Lee, H. Yoon, S. Kim, O. Kwon, H. Hwang, K.-H. Kim, J.-H. Jeon, T.D. Singh, S.W. Kim, S.Y. Hwang, H.-S. Choi, I.-K. Lee, S.H. Kim, Y.H. Jeon, J. Chin, S.J. Cho, Insights of a Lead Optimization Study and Biological Evaluation of Novel 4-Hydroxytamoxifen Analogs as Estrogen-Related Receptor γ (ERRγ) Inverse Agonists, Journal of Medicinal Chemistry. 59 (2016) 10209–10227. doi:10.1021/acs.jmedchem.6b01204.
[31] J. Kim, J. Song, H.D. Ji, E.K. Yoo, J.-E. Lee, S.B. Lee, J.M. Oh, S. Lee, J.S. Hwang, H. Yoon, D.-S. Kim, S.-J. Lee, M. Jeong, S. Lee, K.-H. Kim, H.-S. Choi, S.W. Lee, K.-G. Park, I.-K. Lee, S.H. Kim, H. Hwang, Y.H. Jeon, J. Chin, S.J. Cho, Discovery of Potent, Selective, and Orally Bioavailable Estrogen-Related Receptor-γ Inverse Agonists To Restore the Sodium Iodide Symporter Function in Anaplastic Thyroid Cancer, Journal of Medicinal Chemistry. 62 (2019) 1837–1858. doi:10.1021/acs.jmedchem.8b01296.
[32] R. Suriano, Y. Lin, B.T. Ashok, S.D. Schaefer, S.P. Schantz, J. Geliebter, R.K. Tiwari, Pilot Study Using SELDI-TOF−MS Based Proteomic Profile for the Identification of Diagnostic Biomarkers of Thyroid Proliferative Diseases, Journal of Proteome Research. 5 (2006) 856–861. doi:10.1021/pr050349r.
[33] W.-C. Wang, H.-Y. Shiao, C.-C. Lee, K.-S. Fung, H.-P. Hsieh, Anaplastic lymphoma kinase (ALK) inhibitors: a review of design and discovery, MedChemComm. 5 (2014) 1266–1279. doi:10.1039/C4MD00048J.
[34] O.I. Parisi, C. Morelli, L. Scrivano, M.S. Sinicropi, M.G. Cesario, S. Candamano, F. Puoci, D. Sisci, Controlled release of sunitinib in targeted cancer therapy: smart magnetically responsive hydrogels as restricted access materials, RSC Advances. 5 (2015) 65308–65315. doi:10.1039/C5RA12229E.
[35] L. Naso, M. Valcarcel, P. Villacé, M. Roura-Ferrer, C. Salado, E.G. Ferrer, P.A.M. Williams, Specific antitumor activities of natural and oxovanadium(iv) complexed flavonoids in human breast cancer cells, New Journal of Chemistry. 38 (2014) 2414–2421. doi:10.1039/C3NJ01649H.
[36] B.P. Nair, C.P. Sharma, Poly(lactide-co-glycolide)–Laponite–F68 Nanocomposite Vesicles through a Single-Step Double-Emulsion Method for the Controlled Release of Doxorubicin, Langmuir. 28 (2012) 4559–4564. doi:10.1021/la300005c.
[37] K. Kamiya, S. Takeuchi, Giant liposome formation toward the synthesis of well-defined artificial cells, Journal of Materials Chemistry B. 5 (2017) 5911–5923. doi:10.1039/C7TB01322A.
[38] M. Nabi-Meibodi, A. Vatanara, A.R. Najafabadi, M.R. Rouini, V. Ramezani, K. Gilani, S.M.H. Etemadzadeh, K. Azadmanesh, The effective encapsulation of a hydrophobic lipid-insoluble drug in solid lipid nanoparticles using a modified double emulsion solvent evaporation method, Colloids and Surfaces B: Biointerfaces. 112 (2013) 408–414. doi:https://doi.org/10.1016/j.colsurfb.2013.06.013.
[39] A.Z.M. Badruddoza, S. V MacWilliams, D.A. Sebben, M. Krasowska, D. Beattie, D.J. Durian, J.K. Ferri, Diffusing wave spectroscopy (DWS) methods applied to double emulsions, Current Opinion in Colloid & Interface Science. 37 (2018) 74–87. doi:https://doi.org/10.1016/j.cocis.2018.06.006.
[40] L. Cai, X. Qin, Z. Xu, Y. Song, H. Jiang, Y. Wu, H. Ruan, J. Chen, Comparison of Cytotoxicity Evaluation of Anticancer Drugs between Real-Time Cell Analysis and CCK-8 Method, ACS Omega. 4 (2019) 12036–12042. doi:10.1021/acsomega.9b01142.
[41] G. Jiao, X. He, X. Li, J. Qiu, H. Xu, N. Zhang, S. Liu, Limitations of MTT and CCK-8 assay for evaluation of graphene cytotoxicity, RSC Advances. 5 (2015) 53240–53244. doi:10.1039/C5RA08958A.
[42] H.X. Ren, Q.C. Tang, L. Yan, H. Xia, H.S. Luo, Evodiamine inhibits gastrointestinal motility via CCK and CCK1 receptor in water-avoidence stress rat model, Life Sciences. 209 (2018) 210–216. doi:https://doi.org/10.1016/j.lfs.2018.08.003.
[43] S. Kasibhatla, G.P. Amarante-Mendes, D. Finucane, T. Brunner, E. Bossy-Wetzel, D.R. Green, Acridine Orange/Ethidium Bromide (AO/EB) Staining to Detect Apoptosis, CSH Protocols. 2006 (2006) 799–803. doi:10.1101/pdb.prot4493.
[44] K. Liu, P. Liu, R. Liu, X. Wu, Dual AO/EB staining to detect apoptosis in osteosarcoma cells compared with flow cytometry, Medical Science Monitor Basic Research. 21 (2015) 15–20. doi:10.12659/MSMBR.893327.
[45] W.-H. Zhang, S. Chen, X.-L. Liu, Bing-Lin, X.-W. Liu, Y. Zhou, Study on antitumor activities of the chrysin-chromene-spirooxindole on Lewis lung carcinoma C57BL/6 mice in vivo, Bioorganic & Medicinal Chemistry Letters. 30 (2020) 127410. doi:https://doi.org/10.1016/j.bmcl.2020.127410.
[46] T.E. Yalcin, S. Ilbasmis-Tamer, S. Takka, Antitumor activity of gemcitabine hydrochloride loaded lipid polymer hybrid nanoparticles (LPHNs): In vitro and in vivo, International Journal of Pharmaceutics. 580 (2020) 119246. doi:https://doi.org/10.1016/j.ijpharm.2020.119246.
[47] F.A. Kabeer, D.S. Rajalekshmi, M.S. Nair, R. Prathapan, In vitro and in vivo antitumor activity of deoxyelephantopin from a potential medicinal plant Elephantopus scaber against Ehrlich ascites carcinoma, Biocatalysis and Agricultural Biotechnology. 19 (2019) 101106. doi:https://doi.org/10.1016/j.bcab.2019.101106.